![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/16/2883338/0/en/Chiesi-to-Present-New-Data-Showcasing-Depth-of-Respiratory-Leadership-at-the-American-Thoracic-Society-2024-International-Conference.html
https://www.globenewswire.com/news-release/2023/07/20/2708249/0/en/Chiesi-USA-CEO-Appointed-to-ASHP-Foundation-Board-of-Directors.html
https://www.globenewswire.com/news-release/2023/06/12/2686335/0/en/Chiesi-USA-Partners-with-Smith-Anderson-to-Host-1L-Excellence-in-Diversity-Fellow-this-Summer.html
https://www.ema.europa.eu/en/documents/overview/elfabrio-epar-medicine-overview_en.pdf
https://www.globenewswire.com/news-release/2023/04/11/2644473/0/en/2022-for-Chiesi-The-Group-s-international-growth-continues.html
https://www.prnewswire.com/news-releases/chiesis-international-growth-continues-301790653.html
https://www.prnewswire.com/news-releases/chiesi-global-rare-diseases-announces-approval-of-ferriprox-mr-deferiprone-extended-release-tablets-in-canada-301787472.html
https://www.globenewswire.com/news-release/2023/03/28/2635729/0/en/Chiesi-USA-donates-more-than-830-000-to-local-communities-and-nonprofits-in-2022.html
https://www.globenewswire.com//news-release/2022/12/02/2566743/0/en/Chiesi-USA-Sponsors-ASHP-Advantage-Initiative-to-Support-Pharmacy-Technician-Recruitment-and-Retention.html
https://www.globenewswire.com//news-release/2022/11/29/2564088/0/en/Chiesi-USA-Announces-Publication-of-Health-Economics-Analysis-of-Selective-Early-Rescue-Surfactant-Administration-vs-Standard-Surfactant-Administration-for-Premature-Infants-with-R.html